MC 1324 Nicotinic acid, [carboxyl-14C]- Click here for Typical Certificate of Analysis |
|
| (3-pyridine carboxylic acid, [carboxyl-14C]-) | |
| Delivered ≥ 97% pure with dated HPLC radiochromatogram | |
| Solid | 250 µCi (9.25 MBq) $2475 |
| > 50 mCi(1.85 GBq)/mmol | 1 mCi (37 MBq) $3760 |
| NextGen V-Vial - shipped on dry ice | |
| M.W. 123.11 | |
| This material is pharmaceutically unrefined, and not intended for use in humans, clinical diagnosis, or data derived from its use to support regulatory filings. | |
MC 1168 Nicotinic acid, [pyridyl-2-14C]- |
|
| (3-pyridine carboxylic acid, [pyridyl-2-14C]-) | |
| Delivered ≥ 97% pure with dated HPLC radiochromatogram | |
| Solid | |
| > 45 mCi(1.665 GBq)/mmol | 50 µCi (1.85 MBq) $3970 |
| NextGen V-Vial - shipped on dry ice | 250 µCi (9.25 MBq) $4980 |
| M.W. 123.11 | |
| This material is pharmaceutically unrefined, and not intended for use in humans, clinical diagnosis, or data derived from its use to support regulatory filings. | |